[4] [5] Tirzepatida (Mounjaro, Zepbound) es un agonista dual que acta tanto en receptores GIP como GLP-1
So, what is the key difference
What should I do if I experience brain fog while taking these together
Some women find that maintaining a lower dose (for example, 1.0 mg rather than escalating to 2.4 mg) achieves adequate weight loss with fewer side effects, including sexual ones
Benefits of Ipamorelin Ipamorelin significantly increases plasma growth hormone (GH) levels in both animals and humans.In addition, ipamorelin stimulates body weight gain in animals.Like pralmorelin and GHRP-6, ipamorelin does not affect prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), or thyroid-stimulating hormone (TSH) levels.However, unlike pralmorelin (GHRP-2) and GHRP-6, but similarly to growth hormone-releasing hormone (GHRH), ipamorelin does not stimulate the secretion of adrenocorticotropic hormone (ACTH) or cortisol, and is highly selective for inducing the secretion only of GH
Although GIPR agonists do not require GLP-1R to decrease body weight (179, 184), GIPR agonism was recently shown to attenuate the emetic effects of GLP-1R agonism in mice, rats and musk shrews (188)